Clinical Results:
Clinical Trial Related:
Science
The novel immunomodulatory biologic LMWF5A for pharmacological attenuation of the “cytokine storm” in COVID-19 patients: a hypothesis. -Gregory Thomas, Elizabeth Fredrick, Melissa Hausberg, Laura Goldberg, Marshall Hoke, Michael Roshon, Charles Mains, David Bar-Or
Ampion regulates the immune response
Ampion uses the power of the immune response and is in development to treat osteoarthritis, respiratory illness due to COVID-19, and a wide range of other debilitating and life-threatening inflammatory conditions.